GLG LLC quarter change: USA Bonds: Convertible Notes, Unchanged
In convertible notes that pay a coupon (listed in the US), from the quarter ended 2016-06-30 to 2016-09-30, GLG LLC opened 1 positions, added to 0, reduced 1, sold out of 1 and left 1 unchanged. The largest increase in value was INTERCEPT PHARMACEUTICALS IN (+$6,840,000); the largest decrease was NAVISTAR INTL CORP NEW (-$19,007,000).
- THERAVANCE INC: Country of operation United States; Class NOTE 2.125% 1/1; Principal 2016-06-30 $43,687,000; Principal 2016-09-30 $43,687,000.
Two Form 13F-HR filings compared (SEC CIK 1352261): 2016-06-30 (filed 2016-08-16) and 2016-09-30 (filed 2016-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||